Athens Medical (Greece) Performance
| IATR Stock | EUR 1.54 0.01 0.65% |
The firm shows a Beta (market volatility) of 0.34, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Athens Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Athens Medical is expected to be smaller as well. At this point, Athens Medical CSA has a negative expected return of -0.0471%. Please make sure to confirm Athens Medical's jensen alpha, treynor ratio, and the relationship between the information ratio and total risk alpha , to decide if Athens Medical CSA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Athens Medical CSA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Athens Medical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 49.3 M | |
| Total Cashflows From Investing Activities | -7 M | |
| Free Cash Flow | 4.5 M |
Athens |
Athens Medical Relative Risk vs. Return Landscape
If you would invest 160.00 in Athens Medical CSA on August 24, 2024 and sell it today you would lose (6.00) from holding Athens Medical CSA or give up 3.75% of portfolio value over 90 days. Athens Medical CSA is generating negative expected returns and assumes 1.6022% volatility on return distribution over the 90 days horizon. Simply put, 14% of stocks are less volatile than Athens, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Athens Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Athens Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Athens Medical CSA, and traders can use it to determine the average amount a Athens Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0294
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IATR |
Estimated Market Risk
| 1.6 actual daily | 14 86% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Athens Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Athens Medical by adding Athens Medical to a well-diversified portfolio.
Athens Medical Fundamentals Growth
Athens Stock prices reflect investors' perceptions of the future prospects and financial health of Athens Medical, and Athens Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Athens Stock performance.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0317 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 354.02 M | |||
| Shares Outstanding | 86.74 M | |||
| Price To Earning | 18.79 X | |||
| Price To Book | 0.59 X | |||
| Price To Sales | 0.54 X | |||
| Revenue | 226 M | |||
| EBITDA | 34.78 M | |||
| Cash And Equivalents | 4.59 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 129.39 M | |||
| Debt To Equity | 184.80 % | |||
| Book Value Per Share | 1.17 X | |||
| Cash Flow From Operations | 15.75 M | |||
| Earnings Per Share | 0.12 X | |||
| Total Asset | 422.76 M | |||
| Retained Earnings | 12 M | |||
| Current Asset | 124 M | |||
| Current Liabilities | 271 M | |||
About Athens Medical Performance
Assessing Athens Medical's fundamental ratios provides investors with valuable insights into Athens Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Athens Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Athens Medical Center S.A., together with its subsidiaries, owns and operates hospital units in Greece and Romania. Athens Medical Center S.A. was founded in 1984 and is headquartered in Athens, Greece. ATHENS MEDICAL operates under Health Care Plans classification in Greece and is traded on Athens Stock Exchange.Things to note about Athens Medical CSA performance evaluation
Checking the ongoing alerts about Athens Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Athens Medical CSA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Athens Medical CSA generated a negative expected return over the last 90 days | |
| Athens Medical CSA may become a speculative penny stock | |
| Athens Medical CSA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Athens Medical CSA has accumulated 129.39 M in total debt with debt to equity ratio (D/E) of 184.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Athens Medical CSA has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Athens Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Athens Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Athens Medical CSA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Athens to invest in growth at high rates of return. When we think about Athens Medical's use of debt, we should always consider it together with cash and equity. | |
| About 81.0% of Athens Medical shares are held by company insiders |
- Analyzing Athens Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Athens Medical's stock is overvalued or undervalued compared to its peers.
- Examining Athens Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Athens Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Athens Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Athens Medical's stock. These opinions can provide insight into Athens Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Athens Stock Analysis
When running Athens Medical's price analysis, check to measure Athens Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Athens Medical is operating at the current time. Most of Athens Medical's value examination focuses on studying past and present price action to predict the probability of Athens Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Athens Medical's price. Additionally, you may evaluate how the addition of Athens Medical to your portfolios can decrease your overall portfolio volatility.